Article Versions Notes

Meng X, Bi J, Li Y, Yang S, Zhang Y, Li M, Liu H, Li Y, Mcdonald ME, Thiel KW, et al. AZD1775 Increases Sensitivity to Olaparib and Gemcitabine in Cancer Cells with p53 Mutations. Cancers. 2018; 10(5):149. https://doi.org/10.3390/cancers10050149

Meng, Xiangbing, Jianling Bi, Yujun Li, Shujie Yang, Yuping Zhang, Mary Li, Haitao Liu, Yiyang Li, Megan E. Mcdonald, Kristina W. Thiel, and et al. 2018. "AZD1775 Increases Sensitivity to Olaparib and Gemcitabine in Cancer Cells with p53 Mutations" Cancers 10, no. 5: 149. https://doi.org/10.3390/cancers10050149

Meng, X., Bi, J., Li, Y., Yang, S., Zhang, Y., Li, M., Liu, H., Li, Y., Mcdonald, M. E., Thiel, K. W., Wen, K. -K., Wang, X., Wu, M., & Leslie, K. K. (2018). AZD1775 Increases Sensitivity to Olaparib and Gemcitabine in Cancer Cells with p53 Mutations. Cancers, 10(5), 149. https://doi.org/10.3390/cancers10050149